Photo of Margaret K. Callahan, M.D., Ph.D.

Margaret K. Callahan, M.D., Ph.D.

Chief, Division of Hematology/Oncology
Associate Professor
NPI Number:
Academic Office Location:
Neag Comprehensive Cancer Center
UConn Health
263 Farmington Avenue
Farmington, CT 06030
Phone: 800-579-7822

Neag Comprehensive Cancer Center

Immunology Graduate Program

  • Looking for a Physician?

    This faculty member is also
    a practicing physician at UConn Health.

    Learn more >
B.S.University of ConnecticutMolecular and Cellular Biology
M.D.UConn School of MedicineMedicine
Ph.D.UConn HealthBiomedical Science

Post-Graduate Training
ResidencyUniversity of California at San FranciscoInternal Medicine, Molecular Medicine Training Program
FellowshipMemorial Sloan Kettering Cancer CenterMedical Oncology

Name of Award/HonorAwarding Organization
Science Translational Medicine Associate Scientific AdvisorScience Translational Medicine
Oncology Travel Trainee AwardConquer Cancer Foundation
Clinical Scholars Research Award, 2011-2012Memorial Sloan-Kettering Cancer Center
Connecticut State Medical Society AwardConnecticut State Medical Society
Trainee Travel AwardAmerican Society for Clinical Investigation
Medical Scientist Training Program (MSTP) Trainee, 1999-2007National Institutes of Health
Biotechnology Department Undergraduate Research AwardUniversity of Connecticut
Dean's List (1994-1998)University of Connecticut
New England Scholar, (1994-1998)University of Connecticut
  • Advanced Melanoma
  • Cancer Immunotherapy
  • Checkpoint Blockade
  • Targeted Inhibitors
  • Novel Therapies
  • Biomarker Development
  • Clinical Trials

Margaret Callahan, chief of the division of Hematology and Oncology in the Neag Cancer Center, is a board-certified medical oncologist specializing in the use of immunotherapies to treat melanoma and other cancers. Her research focuses on understanding how immunotherapies work in patients with the goal of characterizing facets of the human immune system that help or hinder the anti-tumor activity of current and novel agents. 

Journal Articles